Imaging of Dysplastic Nodules and Small Hepatocellular Carcinomas: Experience with Explanted LiversKrinsky G.
Department of Radiology, New York University School of Medicine, New York, N.Y., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Differentiation of benign from malignant nodules in the end-stage cirrhotic liver can be challenging, due to the presence of fibrosis, necrosis and altered blood supply. Whole liver explant pathologic correlation provides a unique opportunity to evaluate the sensitivity and specificity of current imaging modalities for the diagnosis of HCC and dysplastic nodules in the cirrhotic liver. This chapter will explore and critique the imaging literature with an emphasis on studies performed with timely explanted liver correlation.
© 2004 S. Karger AG, Basel
Fung J, Marsh W: The quandary over liver transplantation for hepatocellular carcinoma: The greater sin? Liver Transpl 2002;8:775–777.
- El-Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745–750.
- Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–699.
- Ueda K, Terada T, Nakanuma Y, Matsui O: Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: A morphometric study. Hum Pathol 1992;23:619–626.
- Theise ND, Lapook JD, Thung SN: A macroregenerative nodule containing multiple foci of hepatocellular carcinoma in a noncirrhotic liver. Hepatology 1993;17:993–996.
- Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 1995;22:983–993.
- Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND: Neoangiogenesis and sinusoidal ‘capillarization’ in dysplastic nodules of the liver. Am J Surg Pathol 1998;22:656–662.
- Roncalli M, Roz E, Coggi G, Di Rocco MG, Bossi P, Minola E, Gambacorta M, Borzio M: The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: Implications for diagnosis and classification. Hepatology 1999;30:1174–1178.
- Krinsky GA, Theise ND, Rofsky NM, Mizrachi H, Tepperman LW, Weinreb JC: Dysplastic nodules in cirrhotic liver: Arterial phase enhancement at CT and MR imaging – a case report. Radiology 1998;209:461–464.
- Krinsky GA, Zivin SB, Thorner KM, Lee VS, Theise ND, Weinreb JC: Low-grade siderotic dysplastic nodules: Determination of premalignant lesions on the basis of vasculature phenotype. Acad Radiol 2002;9:336–341.
Miller WJ, Baron RL, Dodd GD III, Federle MP: Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 1996;193:645–650.
- Peterson MS, Baron RL, Marsh JW Jr, Oliver JH III, Confer SR, Hunt LE: Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: Epidemiology and CT-based detection rate in 430 cases with surgical pathologic correlation. Radiology 2000;217:743–749.
- Choi D, Kim SH, Lim JH, Cho JM, Lee WJ, Lee SJ, Lim HK: Detection of hepatocellular carcinoma: Combined T2-weighted and dynamic gadolinium-enhanced MRI versus combined CT during arterial portography and CT hepatic arteriography. J Comput Assist Tomogr 2001;25:777–785.
- Fujita T, Ito K, Honjo K, Okazaki H, Matsumoto T, Matsunaga N: Detection of hepatocellular carcinoma: Comparison of T2-weighted breath-hold fast spin-echo sequences and high-resolution dynamic MR imaging with a phased-array body coil. J Magn Reson Imaging 1999;9:274–279.
- Yu JS, Kim KW, Kim EK, Lee JT, Yoo HS: Contrast enhancement of small hepatocellular carcinoma: Usefulness of three successive early image acquisitions during multiphase dynamic MR imaging. AJR Am J Roentgenol 1999;173:597–604.
Tang Y, Yamashita Y, Arakawa A, Namimoto T, Mitsuzaki K, Abe Y, Katahira K, Takahashi M: Detection of hepatocellular carcinoma arising in cirrhotic livers: Comparison of gadolinium- and ferumoxides-enhanced MR imaging. AJR Am J Roentgenol 1999;172:547–554.
- Kelekis NL, Semelka RC, Worawattanakul S, de Lange EE, Ascher SM, Ahn IO, Reinhold C, Remer EM, Brown JJ, Bis KG, Woosley JT, Mitchell DG: Hepatocellular carcinoma in North America: A multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. AJR Am J Roentgenol 1998;170:1005–1013.
- Kanematsu M, Hoshi H, Murakami T, Itoh K, Hori M, Kondo H, Nakamura H: Detection of hepatocellular carcinoma: Comparison of low- and high-spatial-resolution dynamic MR images. AJR Am J Roentgenol 1999;173:1207–1212.
- Yamashita Y, Tang Y, Namimoto T, Mitsuzaki K, Takahashi M: MR imaging of the liver: Comparison between single-shot echo-planar and half-Fourier rapid acquisition with relaxation enhancement sequences. Radiology 1998;207:331–337.
- Krinsky GA, Lee VS, Theise ND, Weinreb JC, Morgan GR, Diflo T, John D, Teperman LW: Transplantation for hepatocellular carcinoma and cirrhosis: Sensitivity of magnetic resonance imaging. Liver Transpl 2002;8:1156–1164.
- Rode A, Bancel B, Douek P, Chevallier M, Vilgrain V, Picaud G, Henry L, Berger F, Bizollon T, Gaudin JL, Ducerf C: Small nodule detection in cirrhotic livers: Evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001;25:327–336.
- Libbrecht L, Bielen D, Verslype C, Vanbeckevoort D, Pirenne J, Nevens F, Desmet V, Roskams T: Focal lesions in cirrhotic explant livers: Pathologic evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002;8:749–761.
- Dodd GD III, Miller WJ, Baron RL, Skolnick ML, Campbell WL: Detection of malignant tumors in end-stage cirrhotic livers: Efficacy of sonography as a screening technique. AJR Am J Roentgenol 1992;159:727–733.
Bennett GL, Krinsky GA, Abitbol RJ, Kim SJ, Theise ND, Teperman LW: Ultrasound detection of hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: Correlation of pretransplant ultrasound findings and liver explant pathology in 200 patients. AJR Am J Roentgenol 2002;179:175–180.
Kim CK, Lim JH, Lee WJ: Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: Accuracy of ultrasonography in transplant patients. J Ultrasound Med 2001;159:99–104.
- Montorsi M, Santambrogio R, Bianchi P, Opocher E, Cornalba GP, Dapri G, Bonavina L, Zuin M, Podda M: Laparoscopy with laparoscopic ultrasound for pretreatment staging of hepatocellular carcinoma: A prospective study. J Gastrointest Surg 2001;5:312–315.
- Lim JH, Kim CK, Lee WJ, Park CK, Koh KC, Paik SW, Joh JW: Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: Accuracy of helical CT in transplant patients. AJR Am J Roentgenol 2000;175:693–698.
- De Ledinghen V, Laharie D, Lecesne R, Le Bail B, Winnock M, Bernard PH, Saric J, Couzigou P, Balabaud C, Bioulac-Sage P, Drouillard J: Detection of nodules in liver cirrhosis: Spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients. Eur J Gastroenterol Hepatol 2002;14:159–165.
- Krinsky GA, Lee VS, Theise ND, Weinreb JC, Rofsky NM, Diflo T, Teperman LW: Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: Prospective diagnosis with MR imaging and explantation correlation. Radiology 2001;219:445–454.
- Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC: Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: Optimization with a test examination and a power injector. Radiology 1997;202:268–273.
- Bhartia B, Ward J, Guthrie JA, Robinson PJ: Hepatocellular carcinoma in cirrhotic livers: Double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR Am J Roentgenol 2003;180:577–584.
- Spreafico C, Marchiano A, Regalia E, Frigerio LF, Garbagnati F, Andreola S, Milella M, Lanocita R, Mazzaferro V: Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology 1994;192:687–690.
- Krinsky GA, Nguyen MT, Lee VS, Rosen RJ, Goldenberg A, Theise ND, Morgan G, Rofsky NM: Dysplastic nodules and hepatocellular carcinoma: Sensitivity of digital subtraction hepatic arteriography with whole liver explant correlation. J Comput Assist Tomogr 2000;24:628–634.
- Lim JH, Cho JM, Kim EY, Park CK: Dysplastic nodules in liver cirrhosis: Evaluation of hemodynamics with CT during arterial portography and CT hepatic arteriography. Radiology 2000;214:869–874.
- Freeny PC, Marks WM: Hepatic perfusion abnormalities during CT angiography: Detection and interpretation. Radiology 1986;159:685–691.
- Paulson EK, Baker ME, Hilleren DJ, Jones WP, Knelson MH, Nadel SN, Leder RA, Meyers WC: CT arterial portography: Causes of technical failure and variable liver enhancement. AJR Am J Roentgenol 1992;159:745–749.
- Taourel PG, Pageaux GP, Coste V, Fabre JM, Pradel JA, Ramos J, Larrey D, Domergue J, Michel H, Bruel JM: Small hepatocellular carcinoma in patients undergoing liver transplantation: Detection with CT after injection of iodized oil. Radiology 1995;197:377–380.
- Spreafico C, Marchiano A, Mazzaferro V, Frigerio LF, Regalia E, Lanocita R, Patelli G, Andreola S, Garbagnati F, Damascelli B: Hepatocellular carcinoma in patients who undergo liver transplantation: Sensitivity of CT with iodized oil. Radiology 1997;203:457–460.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.